• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在哥伦比亚卡利市疫苗接种推广之前及期间,新冠疫情两波流行中的新冠肺炎死亡率。

COVID-19 mortality in two waves of the pandemic in Cali, Colombia, before and during vaccination roll-out.

作者信息

Reina Carlos, Roa Pablo, Garcés Anthony, Valencia Andrés, Torres Miyerlandi, Concha-Eastman Alberto

机构信息

Secretaría de Salud Pública Cali Colombia Secretaría de Salud Pública, Cali, Colombia.

出版信息

Rev Panam Salud Publica. 2023 May 22;47:e76. doi: 10.26633/RPSP.2023.76. eCollection 2023.

DOI:10.26633/RPSP.2023.76
PMID:37223328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10202339/
Abstract

OBJECTIVE

To describe the variation in COVID-19 mortality among residents of Cali, Colombia, in the second wave of the pandemic, before vaccines, and in the fourth wave, with vaccination roll-out in process, taking into account variables of sex, age group, comorbidities, and interval between onset of symptoms and death, and to estimate the number of deaths averted by vaccination.

METHODS

A cross-sectional study of second wave and fourth wave deaths and vaccination coverage. The frequencies of attributes of deceased population in the two waves were compared, including comorbidities. Machado's method was used to calculate an estimate of the number of deaths averted in the fourth wave.

RESULTS

There were 1 133 deaths in the second wave and 754 deaths in the fourth wave. It was calculated that approximately 3 763 deaths were averted in the fourth wave in Cali in the context of vaccination roll-out.

CONCLUSIONS

The decline in COVID-19-associated mortality observed supports the continuation of the vaccination program. Given the lack of data to explain other possible reasons for this decline, such as on the severity of novel viral variants, the limitations of the study are discussed.

摘要

目的

描述在哥伦比亚卡利市居民中,在大流行的第二波(疫苗接种前)和第四波(疫苗接种正在推进)期间,新冠病毒疾病(COVID-19)死亡率的变化情况,同时考虑性别、年龄组、合并症以及症状出现至死亡的时间间隔等变量,并估计疫苗接种避免的死亡人数。

方法

对第二波和第四波死亡情况及疫苗接种覆盖率进行横断面研究。比较了两波死亡人群的属性频率,包括合并症。采用马查多方法计算第四波中避免的死亡人数估计值。

结果

第二波有1133例死亡,第四波有754例死亡。经计算,在卡利市疫苗接种推进的背景下,第四波大约避免了3763例死亡。

结论

观察到的与COVID-19相关的死亡率下降支持继续推行疫苗接种计划。鉴于缺乏数据来解释这种下降的其他可能原因,如新型病毒变体的严重性,对该研究的局限性进行了讨论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e472/10202339/83fe8c92d73e/rpsp-47-e76_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e472/10202339/83fe8c92d73e/rpsp-47-e76_Figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e472/10202339/83fe8c92d73e/rpsp-47-e76_Figure1.jpg

相似文献

1
COVID-19 mortality in two waves of the pandemic in Cali, Colombia, before and during vaccination roll-out.在哥伦比亚卡利市疫苗接种推广之前及期间,新冠疫情两波流行中的新冠肺炎死亡率。
Rev Panam Salud Publica. 2023 May 22;47:e76. doi: 10.26633/RPSP.2023.76. eCollection 2023.
2
A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran.定量评估疫苗推出速度和覆盖率对降低死亡率的影响:来自伊朗 COVID-19 疫情前 2 年的见解。
BMC Med. 2023 Nov 13;21(1):429. doi: 10.1186/s12916-023-03127-8.
3
Epidemiology of 4963 deaths associated with COVID-19 during three pandemic waves in a Latin American city with a high mortality rate, 2020-2021.2020-2021 年,拉丁美洲一个高死亡率城市在三次大流行浪潮中与 COVID-19 相关的 4963 例死亡的流行病学研究。
Trop Med Int Health. 2022 Feb;27(2):158-164. doi: 10.1111/tmi.13707. Epub 2022 Jan 9.
4
Estimated number of deaths directly avoided because of COVID-19 vaccination among older adults in Colombia in 2021: an ecological, longitudinal observational study.2021 年哥伦比亚老年人因 COVID-19 疫苗接种而直接避免死亡的估计人数:一项生态、纵向观察研究。
F1000Res. 2022 Feb 16;11:198. doi: 10.12688/f1000research.109331.3. eCollection 2022.
5
Number of averted COVID-19 cases and deaths attributable to reduced risk in vaccinated individuals in Japan.日本因接种疫苗个体风险降低而避免的新冠病例数和死亡人数。
Lancet Reg Health West Pac. 2022 Nov;28:100571. doi: 10.1016/j.lanwpc.2022.100571. Epub 2022 Aug 11.
6
The Comparison of Clinical Epidemiology of Hospitalized Patients with COVID-19 during the Third and Fourth Waves of the Pandemic in Gorgan.戈尔甘新冠疫情第三波和第四波期间住院COVID-19患者的临床流行病学比较
Can J Infect Dis Med Microbiol. 2022 Dec 31;2022:9634241. doi: 10.1155/2022/9634241. eCollection 2022.
7
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
8
COVID-19 pandemic in Podlaskie Voivodeship - analysis of infection and deaths in 2021.波德拉谢省的新冠疫情——2021年感染情况与死亡情况分析
Przegl Epidemiol. 2022;76(4):469-480. doi: 10.32394/pe.76.44.
9
Comparative Study Between the First and Second Wave of COVID-19 Deaths in India: A Single Center Study.印度新冠疫情第一波与第二波死亡病例的对比研究:一项单中心研究
Cureus. 2023 Apr 12;15(4):e37472. doi: 10.7759/cureus.37472. eCollection 2023 Apr.
10
Impact of the COVID-19 pandemic on routine immunization services in Yerevan and vaccinations against COVID-19 in Armenia.新冠疫情对埃里温常规免疫服务及亚美尼亚新冠疫苗接种的影响。
J Infect Dev Ctries. 2022 Nov 29;16(11):1687-1695. doi: 10.3855/jidc.17028.

引用本文的文献

1
Unveiling the truth: is COVID-19 reimbursement in Colombia a flawed design? A cost-of-illness analysis for moderate, severe and critical infections.揭开真相:哥伦比亚的 COVID-19 报销制度是否存在缺陷?对中度、重度和重症感染的疾病成本分析。
BMJ Open Respir Res. 2024 Apr 5;11(1):e002097. doi: 10.1136/bmjresp-2023-002097.
2
Effectiveness of the Booster Dose in Protecting against COVID-19, Colombia 2022.2022年哥伦比亚加强针预防新冠病毒病的有效性
Vaccines (Basel). 2023 Sep 7;11(9):1461. doi: 10.3390/vaccines11091461.

本文引用的文献

1
Estimated number of deaths directly avoided because of COVID-19 vaccination among older adults in Colombia in 2021: an ecological, longitudinal observational study.2021 年哥伦比亚老年人因 COVID-19 疫苗接种而直接避免死亡的估计人数:一项生态、纵向观察研究。
F1000Res. 2022 Feb 16;11:198. doi: 10.12688/f1000research.109331.3. eCollection 2022.
2
Mortality due to COVID-19 during the vaccination plan against the SARS-CoV-2 virus in Cali, Colombia.在哥伦比亚卡利针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的疫苗接种计划期间,因2019冠状病毒病(COVID-19)导致的死亡情况。
Colomb Med (Cali). 2021 Dec 30;52(4):e7005047. doi: 10.25100/cm.v52i3.5047. eCollection 2021 Oct-Dec.
3
Group Vaccination Five Days before a COVID-19 Outbreak in a Long-Term Care Facility.
长期护理机构新冠疫情爆发前五天进行群体疫苗接种。
Vaccines (Basel). 2021 Dec 8;9(12):1450. doi: 10.3390/vaccines9121450.
4
Effectiveness of BNT162b2 and ChAdOx1 Vaccines against Symptomatic COVID-19 among Healthcare Workers in Kuwait: A Retrospective Cohort Study.BNT162b2和ChAdOx1疫苗对科威特医护人员有症状的COVID-19的有效性:一项回顾性队列研究。
Healthcare (Basel). 2021 Dec 7;9(12):1692. doi: 10.3390/healthcare9121692.
5
Immune Responses in Patients with COVID-19: An Overview.新型冠状病毒肺炎患者的免疫反应:概述。
Pediatr Ann. 2021 May;50(5):e222-e226. doi: 10.3928/19382359-20210421-02. Epub 2021 May 1.
6
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.以色列全国疫苗接种运动后,mRNA BNT162b2疫苗对SARS-CoV-2感染及COVID-19病例、住院和死亡的影响与效果:一项利用国家监测数据的观察性研究
Lancet. 2021 May 15;397(10287):1819-1829. doi: 10.1016/S0140-6736(21)00947-8. Epub 2021 May 5.
7
COVID-19 in Latin America: a first glance to the mortality.拉丁美洲的新冠疫情:对死亡率的初步观察。
Colomb Med (Cali). 2020 Jun 30;51(2):e4366. doi: 10.25100/cm.v51i2.4366.
8
COVID-19 and comorbidities: Deleterious impact on infected patients.COVID-19 与合并症:对感染患者的有害影响。
J Infect Public Health. 2020 Dec;13(12):1833-1839. doi: 10.1016/j.jiph.2020.07.014. Epub 2020 Aug 4.
9
Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) - United States, February 12-March 16, 2020.2020 年 2 月 12 日至 3 月 16 日,美国 2019 冠状病毒病(COVID-19)患者的严重结局。
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):343-346. doi: 10.15585/mmwr.mm6912e2.
10
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病(COVID-19)疫情的特征及重要经验教训:来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.